Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-036674
Filing Date
2022-07-01
Accepted
2022-07-01 16:00:54
Documents
3
Period of Report
2022-07-01

Document Format Files

Seq Description Document Type Size
1 ea162356-6k_scisparc.htm 6-K 13403
2 LETTER AGREEMENT BY AND BETWEEN SCISPARC LTD. AND THE INVESTOR NAMED THEREIN, DA ea162356ex99-1_scisparc.htm EX-99.1 18141
3 AMENDED AND RESTATED ORDINARY SHARE PURCHASE WARRANT, DATED JUNE 30, 2022 ea162356ex99-2_scisparc.htm EX-99.2 101667
  Complete submission text file 0001213900-22-036674.txt   134403
Mailing Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916
Business Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916 972-3-6103100
SciSparc Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 221061310
SIC: 2834 Pharmaceutical Preparations